This was confirmed by less induced expression of the HCC markers AFP and GP3, both in the early (twice daily dosing) and delayed (single daily dosing) treatment group compared to untreated HCC mice (Fig. 7c). This evidence concerns the gene AFP and hepatocellular carcinoma.